{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:37:47Z","timestamp":1791074267793,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.lfs.2013.12.208","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T04:30:20Z","timestamp":1389155420000},"page":"39-43","source":"Crossref","is-referenced-by-count":43,"title":["Activation of PPAR-\u03b3 ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21WAF1: An in vivo study in rats"],"prefix":"10.1016","volume":"98","author":[{"given":"Dexin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2013.12.208_bb0005","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/01.RES.0000073585.50092.14","article-title":"Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth","volume":"92","author":"Ameshima","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.lfs.2013.12.208_bb0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1476-5381.2010.01164.x","article-title":"New perspectives for the treatment of pulmonary hypertension","volume":"163","author":"Baliga","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.lfs.2013.12.208_bb0015","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.rmed.2010.05.009","article-title":"Categorization and impact of pulmonary hypertension in patients with advanced COPD","volume":"104","author":"Cuttica","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.lfs.2013.12.208_bb0020","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1161\/01.CIR.0000016049.86468.23","article-title":"Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma","volume":"105","author":"Diep","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2013.12.208_bb0025","doi-asserted-by":"crossref","first-page":"745804","DOI":"10.1155\/2008\/745804","article-title":"PPAR-gamma in the cardiovascular system","volume":"2008","author":"Duan","year":"2008","journal-title":"PPAR Res"},{"key":"10.1016\/j.lfs.2013.12.208_bb0030","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bbrc.2008.04.086","article-title":"Quantitative expression patterns of peroxisome proliferator-activated receptor-beta\/delta (PPARbeta\/delta) protein in mice","volume":"371","author":"Girroir","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lfs.2013.12.208_bb0035","doi-asserted-by":"crossref","first-page":"L363","DOI":"10.1152\/ajplung.00212.2011","article-title":"The monocrotaline model of pulmonary hypertension in perspective","volume":"302","author":"Gomez-Arroyo","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.lfs.2013.12.208_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/2045-8932.78101","article-title":"Is peroxisome proliferator-activated receptor gamma (PPARgamma) a therapeutic target for the treatment of pulmonary hypertension?","volume":"1","author":"Green","year":"2011","journal-title":"Pulm Circ"},{"key":"10.1016\/j.lfs.2013.12.208_bb0045","doi-asserted-by":"crossref","first-page":"L1082","DOI":"10.1152\/ajplung.00199.2009","article-title":"Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization","volume":"297","author":"Guignabert","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.lfs.2013.12.208_bb0050","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1172\/JCI32503","article-title":"An antiproliferative BMP-2\/PPARgamma\/apoE axis in human and murine SMCs and its role in pulmonary hypertension","volume":"118","author":"Hansmann","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lfs.2013.12.208_bb0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.ATV.0000047447.67827.CD","article-title":"Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension","volume":"23","author":"Iglarz","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.lfs.2013.12.208_bb0060","doi-asserted-by":"crossref","first-page":"H364","DOI":"10.1152\/ajpheart.00979.2001","article-title":"Serial noninvasive assessment of progressive pulmonary hypertension in a rat model","volume":"283","author":"Jones","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.lfs.2013.12.208_bb0065","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1440-1843.2010.01756.x","article-title":"Rosiglitazone attenuates hypoxia-induced pulmonary arterial hypertension in rats","volume":"15","author":"Kim","year":"2010","journal-title":"Respirology"},{"key":"10.1016\/j.lfs.2013.12.208_bb0070","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1742-4658.2010.07581.x","article-title":"Heme oxygenase-1\/p21WAF1 mediates peroxisome proliferator-activated receptor-gamma signaling inhibition of proliferation of rat pulmonary artery smooth muscle cells","volume":"277","author":"Li","year":"2010","journal-title":"FEBS J"},{"key":"10.1016\/j.lfs.2013.12.208_bb0075","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.cellsig.2013.01.021","article-title":"Activation of PPAR-alpha induces cell cycle arrest and inhibits transforming growth factor-beta1 induction of smooth muscle cell phenotype in 10T1\/2 mesenchymal cells","volume":"25","author":"Lien","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.lfs.2013.12.208_bb0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-60761-500-2_20","article-title":"The serotonin hypothesis of pulmonary hypertension revisited","volume":"661","author":"Maclean","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.lfs.2013.12.208_bb0095","first-page":"283","article-title":"et al","volume":"43","author":"Matsuda","year":"2005","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"10.1016\/j.lfs.2013.12.208_bb0105","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/ATVBAHA.109.184234","article-title":"Dominant-negative loss of PPARgamma function enhances smooth muscle cell proliferation, migration, and vascular remodeling","volume":"29","author":"Meredith","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.lfs.2013.12.208_bb0110","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1165\/rcmb.2008-0132OC","article-title":"Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model","volume":"42","author":"Nisbet","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.lfs.2013.12.208_bb0115","doi-asserted-by":"crossref","first-page":"18797","DOI":"10.1155\/2007\/18797","article-title":"The role of peroxisome proliferator-activated receptors in pulmonary vascular disease","volume":"2007","author":"Nisbet","year":"2007","journal-title":"PPAR Res"},{"key":"10.1016\/j.lfs.2013.12.208_bb0125","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.resp.2010.08.009","article-title":"Reactive oxygen species signaling in pulmonary vascular smooth muscle","volume":"174","author":"Perez-Vizcaino","year":"2010","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.lfs.2013.12.208_bb0130","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bbalip.2007.02.013","article-title":"PPARs and molecular mechanisms of transrepression","volume":"1771","author":"Ricote","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.lfs.2013.12.208_bb0135","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.phrs.2011.03.003","article-title":"The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension","volume":"63","author":"Shao","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.lfs.2013.12.208_bb0140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cytogfr.2009.10.007","article-title":"Recent advances in BMP receptor signaling","volume":"20","author":"Sieber","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.lfs.2013.12.208_bb0145","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/heartjnl-2012-301759","article-title":"Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease?","volume":"98","author":"Stone","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.lfs.2013.12.208_bb0150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1253\/circj.CJ-08-1071","article-title":"Peroxisome proliferator-activated receptor gamma and cardiovascular diseases","volume":"73","author":"Takano","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.lfs.2013.12.208_bb0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vph.2005.11.014","article-title":"Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications","volume":"45","author":"Touyz","year":"2006","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.lfs.2013.12.208_bb0160","doi-asserted-by":"crossref","first-page":"L309","DOI":"10.1152\/ajplung.00091.2007","article-title":"Endothelin-1 mediates hypoxia-induced inhibition of voltage-gated K+ channel expression in pulmonary arterial myocytes","volume":"294","author":"Whitman","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.lfs.2013.12.208_bb0165","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jjcc.2012.08.009","article-title":"Recent advances and future perspectives in therapeutic strategies for pulmonary arterial hypertension","volume":"60","author":"Yao","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.lfs.2013.12.208_bb0170","doi-asserted-by":"crossref","first-page":"11505","DOI":"10.1074\/jbc.M110580200","article-title":"Peroxisome proliferator-activated receptor delta is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells","volume":"277","author":"Zhang","year":"2002","journal-title":"J Biol Chem"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320514000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320514000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T15:26:21Z","timestamp":1538925981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320514000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0024320514000034"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2013.12.208","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}